Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results
Go back to Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 108.31 -1.88 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.19 | 52 Week High | $18.39 | |||
| Open | $109.00 | 52 Week Low | $6.96 | |||
| Day High | $109.96 | P/E | N/A | |||
| Day Low | $106.07 | EPS | $-0.58 | |||
| Volume | 1,625,634 | |||||
